- Report
- May 2025
- 193 Pages
Global
From €3111EUR$3,545USD£2,692GBP
€3457EUR$3,939USD£2,991GBP
- Report
- April 2025
- 154 Pages
Global
From €2773EUR$3,160USD£2,400GBP
€3467EUR$3,950USD£2,999GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- February 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- January 2025
- 183 Pages
Global
From €3357EUR$3,825USD£2,905GBP
€3949EUR$4,500USD£3,417GBP
- Report
- March 2025
- 200 Pages
Global
From €3941EUR$4,490USD£3,409GBP
- Report
- August 2024
- 200 Pages
Global
From €4343EUR$4,949USD£3,758GBP
- Report
- November 2024
- 133 Pages
Asia Pacific
From €2984EUR$3,400USD£2,582GBP
€3510EUR$4,000USD£3,037GBP
- Report
- June 2025
- 250 Pages
United States
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2023
- 346 Pages
Global
From €4344EUR$4,950USD£3,759GBP
- Report
- March 2020
- 131 Pages
Global
From €3642EUR$4,150USD£3,151GBP
- Report
- December 2023
- 249 Pages
United States
From €4344EUR$4,950USD£3,759GBP
- Report
- August 2022
- 119 Pages
Global
From €3949EUR$4,500USD£3,417GBP
- Report
- April 2023
- 120 Pages
Global
From €4169EUR$4,750USD£3,607GBP
- Report
- January 2022
- 172 Pages
Global
From €3905EUR$4,450USD£3,379GBP
- Report
- March 2022
- 41 Pages
Global
- Report
- June 2025
- 250 Pages
Vietnam
From €2448EUR$2,789USD£2,118GBP
- Report
- June 2025
- 250 Pages
Saudi Arabia
From €2448EUR$2,789USD£2,118GBP

The 3D Bioprinter market is a subset of the biotechnology industry that focuses on the development and production of 3D bioprinters. These devices are used to create 3D structures from biological materials such as cells, proteins, and other biomaterials. The 3D bioprinting process is used to create tissue-like structures for medical research, drug testing, and tissue engineering. It is also used to create personalized medical implants and prosthetics.
The 3D bioprinting market is expected to grow rapidly in the coming years due to increasing demand for personalized medical implants and prosthetics, as well as the development of new technologies and materials. Additionally, the increasing use of 3D bioprinters in drug discovery and development is expected to drive the market growth.
Some of the major companies in the 3D bioprinting market include Stratasys, 3D Systems, Organovo, EnvisionTEC, Aspect Biosystems, BioBots, and Cyfuse Biomedical. Show Less Read more